Allay Therapeutics (Series D)

Funding Details
Awarder
Inbox
Date Award
June 05, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$57,500,000

Company Info
Company Description
Allay Therapeutics is a clinical-stage biotechnology company providing ultra-sustained analgesic products for post-surgical pain management and recuperation. Its proprietary technology platform combines validated non-opioid analgesics and biopolymers to create dissolvable candidates to deliver pain relief within a targeted site over weeks.
Market
Post-surgical pain management
Location
San Jose, California, USA
Coinvestors
Lightstone Ventures, ClavystBio, NEA, Arboretum Ventures, Vertex Growth, Vertex Ventures Healthcare, Brandon Capital, IPD Capital, EDBI, SGInnovate, HSBC Innovation Banking

Links